Real-time funding, M&A, exec moves & hiring — the signals that move deals
More real-time opportunities that match your ICP — every funding, M&A, and exec move the moment it breaks, with the verified contacts to reach out first.
Funding, M&A, exec moves & hiring — every signal Fundz sees, the moment it happens. See who’s in your market, who to reach, and why now.
Piramal Alternatives Concludes Successful Partnership with Biodeal Pharmaceuticals, Achieving Over 20% IRR.
Jul 30, 2026•10 days ago
Contract Type
partnership
NalagarhBiotechnologyHealth Carepharmaceuticals
Description
Piramal Alternatives has successfully exited its investment in Biodeal Pharmaceuticals, achieving an internal rate of return (IRR) of over 20%. The partnership focused on enhancing Biodeal's operational capabilities and financial performance, leading to significant growth during the investment period.
Company Information
Company
Biodeal Pharmaceuticals
Location
Nalagarh Road
Nalagarh, Himachal Pradesh, India
About
Biodeal Pharmaceuticals is focused on delivering innovative solutions in the healthcare and pharmaceuticals sector. With a commitment to excellence, the company aims to drive growth and enhance patient outcomes. Biodeal is dedicated to exploring new opportunities in a competitive global market.
Predictive Intelligence
Strategic
ML-powered predictions for Biodeal Pharmaceuticals's next move
NalagarhBiotechnologyHealth Carepharmaceuticals